Mincle Signaling Promotes Con A Hepatitis

Stephanie H Greco1, Alejandro Torres-Hernandez1, Aleksandr Kalabin1

  • 1S. Arthur Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, NY 10016;

Insights

This study reveals Mincle (Macrophage-inducible C-type lectin) drives T cell-mediated liver injury in Con A hepatitis. Blocking Mincle protects against this sterile inflammation, highlighting its potential therapeutic role.

Area of Science:

  • Immunology
  • Hepatology
  • Inflammation Research

Background:

  • Concanavalin A (Con A) hepatitis serves as a T cell-mediated acute liver injury model.
  • The C-type lectin receptor Mincle's role in non-pathogen-mediated inflammation is unclear.
  • Mincle's interaction with SAP130 suggests a potential role in Con A hepatitis.

Purpose of the Study:

  • To investigate the role of Mincle signaling in Con A hepatitis.
  • To determine if Mincle blockade can ameliorate liver injury.
  • To elucidate the downstream signaling pathways involved.

Main Methods:

  • Utilized a murine Con A hepatitis model with wild-type, Mincle(-/-), and Dectin-1(-/-) mice.
  • Assessed liver injury and inflammatory cell infiltration.
  • Employed selective inhibitors for C/EBPβ and hypoxia-inducible factor-1α (HIF-1α) signaling.
  • Conducted bone marrow chimeric and adoptive transfer experiments.

Main Results:

  • Mincle expression was elevated in hepatic inflammatory cells and endothelial cells in mice and humans.
  • Mincle deletion or blockade significantly protected against Con A-induced liver injury.
  • Mincle signaling in myeloid cells was critical for disease pathogenesis.
  • Mincle blockade reduced C/EBPβ and HIF-1α signaling, lowering nitrite production.

Conclusions:

  • Mincle acts as a key innate immune driver in Con A hepatitis.
  • Targeting Mincle signaling offers a potential therapeutic strategy for sterile inflammatory liver diseases.
  • This study expands the understanding of Mincle's function beyond pathogen recognition.